SAN DIEGO, Aug. 01, 2024 (GLOBE NEWSWIRE) -- Cibus, Inc. (Nasdaq: CBUS), a leading agricultural technology company that develops and licenses plant traits to seed companies for royalties, today announced that the company will report second quarter 2024 financial results on Thursday, August 8, 2024. Cibus' management team will host a conference call and audio webcast at 4:30 p.m. ET on that day to discuss the financial results and other company updates. Title: Cibus, Inc. Second Quarter 2024 Results Conferen ...

NEW YORK, July 2, 2024 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Cibus, Inc. ("Cibus" or the "Company") (NASDAQ: CBUS). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, ext. 7980. On June 4, 2024, Bonitas Research ("Bonitas") issued a report alleging that it had "found no evidence that Cibus' gene-editing technology brings desirable new crops to market." Bonitas asserted that it had found "farmer complaints of lower crop yields ...

Additional patents issued for 10 plant trait and editing families in the past two quarters. SAN DIEGO, June 26, 2024 (GLOBE NEWSWIRE) -- Cibus, Inc. (Nasdaq: CBUS), a leading agricultural technology company that develops and licenses plant traits to seed companies for royalties, today announced that it has expanded its intellectual property coverage for 10 gene editing and trait families. This intellectual property expansion over the last 6 months covers several areas including gene editing, productivity tr ...

Cibus is a leader in the development of complex gene edited traits in plants like Pod Shatter Reduction in Canola and Herbicide Tolerance in Rice. The Company's plant trait intellectual property is developed using its Rapid Trait Development System (RTDS®) including Gene Repair Oligonucleotides (GRON) and Transcription activator-like effector nuclease (TALEN) technology. About Cibus without limitation, market conditions, failure to satisfy customary closing conditions and the risk factors and other matters ...

BOSTON, June 18, 2024 (GLOBE NEWSWIRE) -- Block & Leviton is investigating Cibus, Inc. (Nasdaq: CBUS) for potential securities law violations. Investors who have lost money in their Cibus investment should contact the firm to learn more about how they might recover those losses. For more details, visit https://blockleviton.com/cases/cbus. Anyone who purchased Cibus common stock and has seen their shares fall may be eligible, whether or not they have sold their investment. Investors should contact Block & Le ...

Nutrient Use Efficiency Traits are an Important Large Category of Traits that can Make Fertilizer Use More Efficient on a Global Basis The First Case of Cibus Using its Trait Machine Process for a Third Party Developed Trait Steve Sanders, PhD and Executive Director of Molecular Discovery and Computational Biology at Cibus, commented, "We are excited with the speed with which we have completed the first edited NUE plants. This was a product of collaboration with a third party to develop this mode of action ...

[Click here for information about joining the class action] Pomerantz LLP, with offices in New York, Chicago, Los Angeles, London, Paris, and Tel Aviv, is acknowledged as one of the premier firms in the areas of corporate, securities, and antitrust class litigation. Founded by the late Abraham L. Pomerantz, known as the dean of the class action bar, Pomerantz pioneered the field of securities class actions. Today, more than 85 years later, Pomerantz continues in the tradition he established, fighting for th ...

SAN DIEGO, June 12, 2024 (GLOBE NEWSWIRE) -- Cibus, Inc. (NASDAQ:CBUS) (the "Company" or "Cibus"), a leading agricultural biotechnology company that uses proprietary gene editing technologies to develop plant traits (or specific genetic characteristics) in seeds, today announced it has entered into securities purchase agreements with institutional, strategic and existing investors of the Company, as well as with the Company's CEO, Rory Riggs, for the purchase and sale of 1,298,040 shares of its Class A Comm ...

What is this all about? Who is eligible? Block & Leviton is investigating whether the Company committed securities law violations and may file an action to attempt to recover losses on behalf of investors who have lost money. If you've lost money on your investment, you should contact Block & Leviton to learn more via our case website, by email at shareholders@blockleviton.com, or by phone at (888) 256-2510. If you have non-public information about Cibus, you should consider assisting in our investigation o ...

NEW YORK, June 06, 2024 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized stockholder rights law firm, is investigating potential claims against Cibus, Inc. ("Cibus" or the "Company") (NASDAQ: CBUS) on behalf of Cibus stockholders. Our investigation concerns whether Cibus has violated the federal securities laws and/or engaged in other unlawful business practices. On June 4, 2024, Bonitas Research published a report alleging, among other things, that "investors have been duped into be ...